People · Operator
Named in public records as an officer, director or promoter · active 2009–2023 · Biotechnology, Other Health Care, Healthtech, Manufacturing
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Apollo Endosurgery Us Inc | — | Biotechnology | Series C | $175.9M | $2.2B | 2009 |
| CardioFocus, Inc. | — | Biotechnology | Series B | $153.2M | $351.9M | 2010 |
| Iconic Therapeutics Inc | — | Biotechnology | Series C | $79.0M | $533.7M | 2014 |
| RxSight, Inc. | — | Other Health Care | Series C | $76.4M | $1.1B | 2017 |
| Clarify Medical, Inc. | — | Healthtech | Series C | $67.6M | $775.6M | 2021 |
| Soft-tex Holdings Inc. | — | Manufacturing | Series A | $10.7M | $106.9M | 2014 |
| Cerephex Corp | — | Other Health Care | Series A | $5.9M | $119.5M | 2012 |
Bruce Robertson at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Bruce Robertson on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| PAUL LAVIOLETTE | 2 | 12 |
| David F Hale | 1 | 16 |
| Jack Nielsen | 1 | 13 |
| Todd Foley | 1 | 12 |
| William Link | 1 | 11 |
| Juliet Bakker | 1 | 9 |
| Robert Garber | 1 | 8 |
| Ross Jaffe | 1 | 7 |
| Charles Larsen | 1 | 7 |
| Peter Hirth | 1 | 7 |
| Bruce Cohen | 1 | 7 |
| William Greene | 1 | 6 |
| JACK KAVANAUGH | 1 | 6 |
| James Garvey | 1 | 6 |
| Jack B. Nielsen | 1 | 6 |
| John Creecy | 1 | 5 |
| J. Andy Corley | 1 | 5 |
| Johan Kordel | 1 | 4 |
| Dennis McWilliams | 1 | 4 |
| Rick Anderson | 1 | 4 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.